Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia

Haematologica

Volumn 101, Issue 11, 2016, Pages 1333-1342

  Melazzini, Federica ^a   Palombo, Flavia ^b   Balduini, Alessandra ^c,d   De Rocco, Daniela ^e   Marconi, Caterina ^b   Noris, Patrizia ^a   Gnan, Chiara ^e   Pippucci, Tommaso ^b   Bozzi, Valeria ^a   Faleschini, Michela ^e   Barozzi, Serena ^a   Doubek, Michael ^f   Di Buduo, Christian A ^c   Kozubik, Katerina Stano ^g   Radova, Lenka ^g   Loffredo, Giuseppe ^h   Pospisilova, Sarka ^g   Alfano, Caterina ⁱ   Seri, Marco ^b   Balduini, Carlo L ^a   Pecci, Alessandro ^a   Savoia, Anna ^e   more..

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d Tufts University   (United States)

^e INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^f UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^g MASARYK UNIVERSITY   (Czech Republic)

^h SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN; FIBRINOGEN; GLYCOPROTEIN; RISTOCETIN; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; VON WILLEBRAND FACTOR; ANKRD26 PROTEIN, HUMAN; NUCLEAR PROTEIN; REPRESSOR PROTEIN; RUNX1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR ETS;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANEMIA; ARTICLE; BIOINFORMATICS; BLEEDING TENDENCY; CELL SPREADING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; MALE; MEGAKARYOCYTE; MIDDLE AGED; MOLECULAR DOCKING; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; YOUNG ADULT; CELL TRANSFORMATION; FAMILY; GENETIC PREDISPOSITION; GENETICS; INFANT; MUTATION; NEWBORN; PATHOLOGY; PEDIGREE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FAMILY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; PEDIGREE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; THROMBOCYTOPENIA; YOUNG ADULT;

EID: 84994654361     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2016.147496     Document Type: Article

References (26)

1. Pecci A. Diagnosis and treatment of inherited thrombocytopenias. Clin Genet. 2016; 89 (2): 141-153.
2. Savoia A. Molecular basis of inherited thrombocytopenias. Clin Genet. 2016: 89 (2): 154-162.
3. Moriyama T, Metzger ML, Wu G, et al. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study. Lancet Oncol. 2015; 16 (16): 1659-1666.
4. Noetzli L, Lo RW, Lee-Sherick AB, et al. Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia. Nat Genet. 2015; 47 (5): 535-538.
5. Topka S, Vijai J, Walsh MF, et al. Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia. PLoS Genet. 2015; 11 (6): e1005262.
6. Zhang MY, Churpek JE, Keel SB, et al. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet. 2015; 47 (2): 180-185.
7. Lowe GC, Lordkipanidzé M, Watson SP. Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders. J Thromb Haemost. 2013; 11 (9): 1663-1668.
8. Noris P, Biino G, Pecci A, et al. Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. Blood. 2014; 124 (6): e4-e10.
9. Noris P, Guidetti GF, Conti V, et al. Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia. Thromb Haemost. 2006; 95 (3): 483-489.
10. Psaila B, Bussel JB, Linden MD, et al. In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation. Blood. 2012; 119 (17): 4066-4072.
11. Pecci A, Bozzi V, Panza E, et al. Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells. Thromb Haemost. 2011; 106 (4): 693-704.
12. Canobbio I, Catricalà S, Di Pasqua LG, et al. Immobilized amyloid A peptides support platelet adhesion and activation. FEBS Lett. 2013; 587 (16): 2606-2611.
13. Pecci A, Malara A, Badalucco S, et al. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation. Thromb Haemost. 2009; 102 (1): 90-96.
14. Bluteau D, Balduini A, Balayn N, et al. Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation. J Clin Invest. 2014; 124 (2): 580-591.
15. Balduini A, Di Buduo CA, Malara A, et al. Constitutively released adenosine diphosphate regulates proplatelet formation by human megakaryocytes. Haematologica. 2012; 97 (11): 1657-1665.
16. Di Buduo CA, Moccia F, Battiston M, et al. The importance of calcium in the regulation of megakaryocyte function. Haematologica. 2014; 99 (4): 769-778.
17. National Cancer Institute. Cancer statistics. Available at: www.seer.cancer.gov/statistics/. Accessed December 20, 2015.
18. Hock H, Meade E, Medeiros S, et al. Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev. 2004; 18 (19): 2336-2341.
19. Bohlander SK. ETV6: a versatile player in leukemogenesis. Semin Cancer Biol. 2005; 15 (3): 162-174.
20. De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris MJ, Basinko A, De Braekeleer M. ETV6 fusion genes in hematological malignancies: a review. Leuk Res. 2012; 36 (8): 945-961.
21. Wang Q, Dong S, Yao H, et al. ETV6 mutation in a cohort of 970 patients with hematologic malignancies. Haematologica. 2014; 99 (10): e176-178.
22. Noris P, Favier R, Alessi MC, et al. ANKRD26-related thrombocytopenia and myeloid malignancies. Blood. 2013; 122 (11): 1987-1989.
23. Liew E, Owen C. Familial myelodysplastic syndromes: a review of the literature. Haematologica. 2011; 96 (10): 1536-1542
24. Owen CJ, Toze CL, Koochin A, et al. Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood. 2008; 112 (12): 4639-4645.
25. Churpek JE, Artz A, Bishop M, Liu H, Godley LA. Correspondence regarding the consensus statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues. Biol Blood Marrow Transplant. 2016; 22 (1): 183-184.
26. Noris P, Perrotta S, Bottega R, et al. Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb (Bolzano mutation). Haematologica. 2012; 97 (1): 82-88.